. La-moyenne-d, 1,3 * 13,7 ans chez les sujets n'ayant pas de syndrome métabolique à 53,2 * 10,9 ans chez les sujets répondant aux cinq critères. Il n'y a pas de différence significative entre les groupes SM3 à SM5 (Tab.59)

R. Le and S. De, 95 0,10) à SM5 (1 '08 k 0,04) Les différences ne sont pas significatives entre les groupes SM3 et SM4

E. Est-la-plus-faible-dans-le-groupe and S. , 8 % 9,9 %) Les différences ne sont pas significatives entre les groupes

E. Est-la-plus-faible-dans-le-groupe and S. , 1 * 5,6 kg) et la plus forte dans le groupe SM5 (1 1,3 h 3'03 kg) Les différences ne sont cependant significatives qu'entre les groupes SM0 et SM3

E. Est-la-plus-faible-dans-le-groupe and S. , 5 kg) et la plus forte dans le groupe SM5 (29,l % 4,6 kg) Les différences ne sont cependant significatives qu'entre les groupes SM0 et SM5

S. Il-augmente-de, 55 h 0,07) à SM4 (0,62 h 0,045) Il n'y a cependant pas de différence significative entre les groupes

S. Il-augmente-de, 12 h 0'12) à SM4 (1,205 Jc 0,085). 11 n'y a cependant pas de différence significative entre les groupes

L. Sujets and S. Ont-le-moins-de-masse-grasse-abdominale, Il n'y a cependant pas de différence significative entre les groupes SM3 à SM5 (Tab.60), p.4336

S. Il-augmente-de, 24 k 0,16) à SM5 (0,40 f 0,12) Les différences ne sont pas significatives entre SM3 et SM4

L. Hommes-ayant-un-syndrome-métabolique-ont, *plus de masse grasse totale en % et en kg *plus de masse grasse du tronc et de l'abdomen en % *plus de masse grasse appendiculaire en kg *un rapport masse grasse appendicelcorps plus bas *un rapport masse grasse tronclcorps plus élevé *un rapport masse grasse tronclmembres inférieurs plus élevé *un rapport masse grasse abdomenljambes plus élevé On ne met

J. Vague, Sexual differentiation, a factor affecting the forrns of obesity, Presse Méd, vol.30, pp.339-340, 1947.

M. Albrink and J. Meigs, THE RELATIONSHIP BETWEEN SERUM TRIGLYCERIDES AND SKINFOLD THICKNESS IN OBESE SUBJECTS, Annals of the New York Academy of Sciences, vol.13, issue.1 Adipose Tissu, pp.673-683, 1965.
DOI : 10.1111/j.1749-6632.1963.tb15776.x

P. Avogaro, G. Crepaldi, G. Enzi, and A. Tiengo, Associazione di iperlipidemia, diabete mellito e obesità di medio grado, Acta Diabetol Lat, vol.4, pp.36-41, 1967.
DOI : 10.1007/bf01544100

T. Welborn, A. Breckenridge, A. Rubinstein, C. Dollery, and T. Fraser, S e m insulin in essential hypertension and in peripheral vascular disease, Lancet, vol.1, pp.1336-1337, 1966.

M. Krotkiewski, P. Bjorntorp, L. Sjostrom, and U. Smith, Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution., Journal of Clinical Investigation, vol.72, issue.3, pp.1-150, 1983.
DOI : 10.1172/JCI111040

A. Kissebah, N. Vydelingum, and R. Murray, Relation of Body Fat Distribution to Metabolic Complications of Obesity*, The Journal of Clinical Endocrinology & Metabolism, vol.54, issue.2, pp.254-260, 1982.
DOI : 10.1210/jcem-54-2-254

M. Stern and S. Haffner, Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.6, issue.2, pp.123-130, 1986.
DOI : 10.1161/01.ATV.6.2.123

M. Modan, H. Halkin, and S. Almog, Hyperinsulinemia. A link between hypertension obesity and glucose intolerance., Journal of Clinical Investigation, vol.75, issue.3, pp.809-817, 1985.
DOI : 10.1172/JCI111776

G. Reaven and . Banting-lecture, Role of Insulin Resistance in Human Disease, Diabetes, vol.37, issue.12, pp.1595-1607, 1988.
DOI : 10.2337/diab.37.12.1595

N. Kaplan, S. Fujioka, Y. Matsuzawa, K. Tokunaga, and S. Tarui, The Deadly Quartet and the Insulin Resistance Syndrome: An Historical Overview, Hypertension Research, vol.19, issue.SupplementI, pp.9-10, 1987.
DOI : 10.1291/hypres.19.SupplementI_S9

J. Després and . Lemieux-1, Treatment of obesity: need to focus on high risk abdominally obese patients, BMJ, vol.322, issue.7288, pp.716-720, 2001.
DOI : 10.1136/bmj.322.7288.716

K. Alberti and P. Zimmet, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation, Diabetic Medicine, vol.15, issue.7, pp.539-553, 1998.
DOI : 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S

B. Balkau and M. Charles, Comrnent on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR), Diabet Med, vol.16, pp.442-443, 1999.

S. Grundy, H. Brewer, J. Cleeman, S. Smith, C. Lenfant et al., for the Conference Participants Definition of Metabolic SyndromeAmerican Heart Association Conference on Scientific Issues Related to Definition 8. 21. The International Diabetes Syndrome Consensus Worldwide Definition of the Metabolic SyndromeHypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men, Report of the National Heart, Lung, and Blood Institute Circulation Circulation, vol.109, issue.102, pp.433-43179, 2000.

B. Balkau, M. Charles, T. Drivsholm, K. Borch-johnsen, N. Wareham et al., European Group For The Study Of Insulin Resistance (EGIR). Frequency of the WHO Metabolic Syndrome in European Cohorts, and an alternative definition of an Insulin Resistance Syndrome, Diabetes Metab, vol.28, pp.364-376, 2002.

E. Ford, W. Giles, D. Walexander, C. Landsmann, P. Teutsch et al., Prevalence of the Metabolic Syndrome Among US AdultsFindings from the Third Hational Health and Nutrition Examination Survey, -defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Arnong N.H.A.N.E.S.111 Participants aged 50 years and older, pp.356-359, 2002.

E. E. Eschwege, . Study, and . Group, The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D, E.S.I.R. study. Diabetes Metab, pp.29526-29558, 2003.

P. Marques-vidal, E. Mazoyer, V. Bongard, P. Gourdy, J. Ruidavets et al., Prevalence of Insulin Resistance Syndrome in Southwestern France and Its Relationship With Inflammatory and Hemostatic Markers, Diabetes Care, vol.25, issue.8, pp.137-138, 2002.
DOI : 10.2337/diacare.25.8.1371

S. Maumus, M. B. Siest, and G. , A Prospective Study on the Prevalence of Metabolic Syndrome Among Healthy French Families: Two cardiovascular risk factors (HDL cholesterol and tumor necrosis factor-??) are revealed in the offspring of parents with metabolic syndrome, Diabetes Care, vol.28, issue.3, pp.675-682, 2005.
DOI : 10.2337/diacare.28.3.675

G. Hu, Q. Qiao, J. Tuomilehto, B. Balkau, K. Borch-johnsen et al., Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and Women, Archives of Internal Medicine, vol.164, issue.10, pp.1066-1076, 2004.
DOI : 10.1001/archinte.164.10.1066

V. Athyros, E. Ganotakis, M. Elisaf, and D. Mikhailidis, The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions, Current Medical Research and Opinion, vol.21, issue.8, pp.157-158, 2005.
DOI : 10.1185/030079905X53333

L. Pucci, D. Prato, and S. , Prevalence of the metabolic syndrome among Italian adults according to ATP III definition, Nutr Metab Cardiovasc Dis, vol.15, pp.250-254, 2005.

E. Alegria, A. Cordero, M. Laclaustra, A. Grima, M. Leon et al., Prevalencia del s??ndrome metab??lico en poblaci??n laboral espa??ola: registro MESYAS, Lehmann R, au nom du groupe de travail «Le syndrome métabolique)). Propositions émises par un groupe de travail interdisciplinaire relatives au diagnostic et au traitement du syndrome métabolique, pp.797-806, 2005.
DOI : 10.1157/13077231

J. Reusch, Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome, The American Journal of Cardiology, vol.90, issue.5, pp.19-26, 12002.
DOI : 10.1016/S0002-9149(02)02555-9

E. Ferrannini, G. Buzzigoli, R. Bonadonna, M. Giorico, M. Oleggini et al., Insulin Resistance in Essential Hypertension, New England Journal of Medicine, vol.317, issue.6, pp.350-357, 1987.
DOI : 10.1056/NEJM198708063170605

J. Pickup, M. Mattock, G. Chusney, and D. Burt, NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X, Diabetologia, vol.23, issue.2, pp.1286-1292, 1997.
DOI : 10.1002/eji.1830230950

N. Ofmeara, J. Blackman, D. Ehrmann, R. Barnes, J. Jaspan et al., Defects in beta-ce11 function in functional ovarian hyperandrogenism, J Clin Endocrinol Metab, vol.76, pp.124-125, 1993.

M. Weitzman, S. Cook, P. Auinger, T. Florin, S. Daniels et al., Tobacco Smoke Exposure Is Associated With the Metabolic Syndrome in Adolescents, Circulation, vol.112, issue.6, pp.122362-869, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.520650

S. Lewington, R. Clarke, N. Qizilbash, R. Peto, and R. Collins, Prospective Studies Collaboration Age-specific relevance of usual blood pressure to vascular mortality: a metaanalysis of individual data for one million adults in 61 prospective studies, Lancet, vol.360, pp.1903-1913, 2002.

M. Hanefeld, S. Fischer, J. U. Schulze, J. Schwanebeck, U. Schmechel et al., Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up, Diabetologia, vol.39, issue.12, pp.1577-1583, 1996.
DOI : 10.1007/s001250050617

K. Berger, H. Schulte, F. Stogbauer, and G. Assmann, Incidence and Risk Factors for Stroke in an Occupational Cohort : The PROCAM Study, Stroke, vol.29, issue.8, pp.1562-1566, 1998.
DOI : 10.1161/01.STR.29.8.1562

M. Laakso, Myocardial infarct size and mortality in patients with non-insulin-dependent diabetes mellitus, J Intern Med, vol.236, pp.291-297, 1994.

W. Kannel, Lipids, diabetes, and coronary heart disease: Insights from the Framingham Study, American Heart Journal, vol.110, issue.5, pp.1100-1107, 1985.
DOI : 10.1016/0002-8703(85)90224-8

M. Wei, S. Gaskill, S. Haffner, and M. Stern, Effects of Diabetes and Level of Glycemia on All-Cause and Cardiovascular Mortality: The San Antonio Heart Study, Diabetes Care, vol.21, issue.7, pp.1167-1172, 1998.
DOI : 10.2337/diacare.21.7.1167

W. Lee, A. Cheung, D. Cape, and B. Zinman, Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies, Diabetes Care, vol.23, issue.7, pp.962-968, 2000.
DOI : 10.2337/diacare.23.7.962

O. Vaccaro, J. Stamler, and J. Neaton, Sixteen-year coronary mortality in black and white men with diabetes screened for the Multiple Risk Factor Intervention Trial (MRFIT), International Journal of Epidemiology, vol.27, issue.4
DOI : 10.1093/ije/27.4.636

A. Fagot-campagna, B. Balkau, D. Simon, P. Ducimetiere, and E. Eschwege, Is insulin an independent risk factor for hypertension? The Paris Prospective Study, International Journal of Epidemiology, vol.26, issue.3, pp.542-550, 1997.
DOI : 10.1093/ije/26.3.542

N. Miller, D. Thelle, O. Forde, and O. Mjos, The Tromso heart-study. Highdensity lipoprotein and coronary heart-disease: a prospective case-control study, Lancet, vol.1, pp.965-968, 1977.

G. Assmann, H. Schulte, and A. Von-eckardstein, Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men, The American Journal of Cardiology, vol.77, issue.14, pp.1179-1184, 1996.
DOI : 10.1016/S0002-9149(96)00159-2

M. Austin, J. Hokanson, and K. Edwards, Hypertriglyceridemia as a Cardiovascular Risk Factor, The American Journal of Cardiology, vol.81, issue.4, pp.7-12, 1998.
DOI : 10.1016/S0002-9149(98)00031-9

M. Stern, K. Williams, C. Gonzalez-villalpando, K. Hunt, S. Haffner et al., Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease?, Diabetes Care, vol.27, issue.11, pp.2676-268, 2004.
DOI : 10.2337/diacare.27.11.2676

N. Sattar, A. Gaw, O. Scherbakova, F. 1. , O. Reilly et al., Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men, Circulation Stroke, vol.108, issue.36, pp.1212-1217, 2003.

L. Groop, Cardiovascular morbidity and mortality associated with the metabolic syndrome, Diabetes Care, vol.24, pp.683-689, 2001.

H. Lakka, D. Laaksonen, T. Lakka, L. Niskanen, E. Kumpusalo et al., The metabolic syndrome and total and cardiovascular disease moriality in middle-aged menThe European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): 1. Methodology and objectives, JAMA Diabetologia, vol.288, issue.47, pp.2709-2716566, 2002.

M. Carnethon, C. Loria, J. Hill, S. Sidney, P. Savage et al., Risk Factors for the Metabolic Syndrome: The Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001, Diabetes Care, vol.27, issue.11, pp.2707-2715, 1985.
DOI : 10.2337/diacare.27.11.2707

G. Ailhaud, Molecular mechanisms of adipocyte differentiation, Journal of Endocrinology, vol.155, issue.2, pp.201-202, 1997.
DOI : 10.1677/joe.0.1550201

O. Ziegler, D. Quilliot, and B. Guerci, Drouin P : Macronutrients, fat mass, fatty acid flux and insulin sensitivity, Diabetes Metab, vol.27, pp.26-27, 2001.

E. J. Danforth and G. Reach, Failure of adipocyte differentiation causes type 2 diabetes mellitus ? Does obesity protect against diabetes? A new controversy, Nat Genet, vol.26, 2000.

E. Marsaudon, Le tissu adipeux : réservoir énergétique et glande endocrine, Le Concours Médical, vol.127, pp.1332-1335, 2005.

E. Kershaw and J. Flier, Adipose Tissue as an Endocrine Organ, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.6, pp.2548-2556, 2004.
DOI : 10.1210/jc.2004-0395

P. Havel, Update on Adipocyte Hormones: Regulation of Energy Balance and Carbohydrate/Lipid Metabolism, Diabetes, vol.53, issue.Supplement 1, pp.143-158, 2004.
DOI : 10.2337/diabetes.53.2007.S143

A. Pittas, N. Joseph, and A. Greenberg, Adipocytokines and Insulin Resistance, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.2, pp.447-452, 2004.
DOI : 10.1210/jc.2003-031005

URL : https://academic.oup.com/jcem/article-pdf/89/2/447/10742151/jcem0447.pdf

B. Wajchenberg, Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome, Endocrine Reviews, vol.21, issue.6, pp.697-738, 2000.
DOI : 10.1210/edrv.21.6.0415

L. Michalik, B. Desvergne, and W. Wahli, Les bases mol??culaires de l'ob??sit?? : vers de nouvelles cibles th??rapeutiques ?, m??decine/sciences, vol.16, issue.10, pp.1030-1031, 2000.
DOI : 10.4267/10608/1521

M. Carr and J. Brunzell, Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.6, pp.2601-2607, 2004.
DOI : 10.1210/jc.2004-0432

N. Abate, A. Garg, R. Peshock, J. Stray-gundersen, and S. Grundy, Relationships of generalized and regional adiposity to insulin sensitivity in men., Journal of Clinical Investigation, vol.96, issue.1, pp.88-98, 1995.
DOI : 10.1172/JCI118083

D. Kelley, F. Thaete, F. Troost, T. Huwe, and B. Goodpaster, Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance, American Journal of Physiology-Endocrinology and Metabolism, vol.4, issue.5, pp.941-948, 2000.
DOI : 10.1111/j.1749-6632.1959.tb44923.x

T. Blaudeau, S. Krishnaswami, T. Harris, A. Katsiaras, S. Kritchevsky et al., Intra-abdominal adipose tissue eut-points related to elevated cardiovascular risk in women Obesity, regional body fat distribution, and the metabolic syndrome in older men and women, Int J Obes Relat Metab DisordArch Intern Med, vol.20, issue.165, pp.613-6777, 1996.

M. Diamant, H. Lamb, M. Van-de-ree, E. Endert, Y. Groeneveld et al., The Association between Abdominal Visceral Fat and Carotid Stiffness Is Mediated by Circulating Inflammatory Markers in Uncomplicated Type 2 Diabetes, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.3, pp.1495-501, 2005.
DOI : 10.1210/jc.2004-1579

R. Stolk, R. Meijer, W. Mali, and D. Grobbee, van der Graaf Y; Secondary Manifestations of Arterial Disease Study Group.Ultrasound measurements of intraabdominal fat estimate the metabolic syndrome better than do measurements of waist circumference, Am J Clin Nutr, pp.77957-860, 2003.

S. Kim, H. Kim, K. Hur, S. Choi, C. Ahn et al., Visceral fat thickness measured by ultrasonography can estimate not only visceral obesity but also risks of cardiovascular and metabolic diseases, Contributions of total and regional fat mass to risk for cardiovascular disease in older women, pp.593-599, 2004.
DOI : 10.1016/0002-9149(94)90676-9

M. Pouliot, J. Despres, S. Lemieux, S. Moorjani, C. Bouchard et al., Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women, The American Journal of Cardiology, vol.73, issue.7, pp.460-468, 1994.
DOI : 10.1016/0002-9149(94)90676-9

. Janssen-1, P. Katzmarzyk, and R. Ross, Waist circumference and not body mass index explains obesity-related health risk, The American Journal of Clinical Nutrition, vol.92, issue.3, pp.379-384, 2004.
DOI : 10.1016/0895-4356(91)90265-B

S. Wannamethee, A. Shaper, R. Morris, and P. Whincup, Measures of adiposity in the identification of metabolic abnormalities in elderly men, The American Journal of Clinical Nutrition, vol.24, issue.suppl, pp.1313-1321, 2005.
DOI : 10.1093/pubmed/24.4.285

K. Wexrode, V. Carey, C. Hennekens, E. Walters, G. Coiditz et al., Abdominal Adiposity and Coronary Heart Disease in Women, JAMA, vol.280, issue.21, pp.1843-1848, 1998.
DOI : 10.1001/jama.280.21.1843

H. Lakka, T. Lakka, J. Tuomilehto, and J. Salonen, Abdominal obesity is associated with increased risk of acute coronary events in men, European Heart Journal, vol.23, issue.9, pp.706-713, 2002.
DOI : 10.1053/euhj.2001.2889

J. Despres, Health consequences of visceral obesity, Annals of Medicine, vol.25, issue.1, pp.33534-33575, 2001.
DOI : 10.1038/sj.ijo.0801540

H. Kahn and R. Valdez, Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration, The American Journal of Clinical Nutrition, vol.97, issue.5, pp.928-934, 2003.
DOI : 10.1161/01.CIR.97.11.1029

J. Moitra, M. Mason, M. Olive, D. Krylov, O. Gavrilova et al., Life without white fat: a transgenic mouse Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophyDunnigan variety), 18 1. 92. Van Maldergem L, pp.168-3722, 1998.

J. Capeau, J. Magré, C. Vigouroux, M. Caron, M. Maachi et al., Diabètes et syndromes lipodystrophiques génétiques et acquis. Flammarion Médecine-Sciences-Journées de, -1 10. 95. Herbst KL, 2003.

J. Viard, Syndromes lipodystrophiques des patients infectés par le VIH recevant un traitement antirétroviral. Flammarion Médecine-Sciences-Journées de, Diabétologie, vol.11, pp.1-122, 2003.

S. Jingu and M. Sakamoto, Excess accumulation of body fat is related to dyslipidemia in normalweight subjects, Int J Obes Relat Metab Disord, vol.28, pp.242-247, 2004.

M. Tatsukawa, M. Kurokawa, Y. Tamari, H. Yoshimatsu, and T. Sakata, Regional fat deposition in the legs is useful as a presumptive marker of antiatherogenesity

M. Williams, G. Hunter, T. Kekes-szabo, S. Snyder, and M. Treuth, Regional fat distribution in w m e n md risk of cardiovascuku disease, Proc Soc Exp Bi01 Med, pp.156-157, 1997.

R. Terry, M. Stefanick, W. Haskell, and P. Wood, Contributions of regional adipose tissue depots to plasma lipoprotein concentrations in overweight men and women: Possible protective effects of thigh fat, Metabolism, vol.40, issue.7, pp.733-740, 1991.
DOI : 10.1016/0026-0495(91)90093-C

O. Ziegler, L. Pelletier, P. Bohme, D. Quilliot, A. Makdissy et al., De l'obésité lipodystrophique au diabète de type 2 : « le syndrome super X » un nouvel abord de l'insulino-résistance, nutrition et métabolisme, pp.137-155, 2004.

G. Reaven, The Metabolic Syndrome: Requiescat in Pace, Clinical Chemistry, vol.51, issue.6, pp.931-938, 2005.
DOI : 10.1373/clinchem.2005.048611

E. Ford, A. Mokdad, and W. Giles, Trends in Waist Circumference among U.S. Adults, Obesity Research, vol.58, issue.Suppl 4, pp.397-405, 2001.
DOI : 10.1016/S0168-8227(02)00125-0

S. Malik, N. Wong, S. Franklin, T. Kamath, L. Italien et al., Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults, Circulation, vol.110, issue.10, pp.1245-12503069, 2002.
DOI : 10.1161/01.CIR.0000140677.20606.0E

J. Yarnell, C. Patterson, D. Bainton, and P. Sweetnam, Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies, Heart, vol.79, issue.3, pp.248-252, 1998.
DOI : 10.1136/hrt.79.3.248

P. Ridker, J. Buring, N. Cook, and N. Rifai, C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women, Circulation, vol.107, issue.3, pp.391-397, 2003.
DOI : 10.1161/01.CIR.0000055014.62083.05

M. Rutter, J. Meigs, L. Sullivan, D. Agostino, R. Wilson et al., C-Reactive Protein, the Metabolic Syndrome, and Prediction of cardiovascular Events in the Framigham Offspring Study, Circulation, vol.1, pp.10-80, 2004.

M. Kumada, S. Kihara, S. Sumitsuji, T. Kawamoto, S. Matsumoto et al., Association of hypoadiponectimia With Coronary Artery Disease in Men, Arteriosclerosis, Thrombosis and Vascular Biology, vol.1, issue.23, pp.85-89, 2003.

E. Ferrannini and B. Balkau, Insulin: in search of a syndrome, Diabetic Medicine, vol.10, issue.9, pp.724-729, 2002.
DOI : 10.1161/01.CIR.103.4.513

T. Garvey, Critical Evaluation of Adult Treatment Panel III Criteria in IdentiSring Insulin Resistance With Dyslipidemia, Diabetes Care, vol.27, pp.978-983, 2004.

D. Carr, K. Utzschneider, R. Hull, K. Kodama, B. Retzlaff et al., Intra-Abdominal Fat Is a Major Determinant of the National Cholesterol Education Program Adult Treatment Panel III Criteria for the Metabolic Syndrome, Diabetes, vol.53, issue.8, pp.2087-2094, 2004.
DOI : 10.2337/diabetes.53.8.2087

A. Hanley, A. Karter, K. Williams, A. Festa, D. Agostino et al., Prediction of Type 2 Diabetes Mellitus With Alternative Definitions of the Metabolic Syndrome: The Insulin Resistance Atherosclerosis Study, Circulation, vol.112, issue.24, pp.3713-3721, 2005.
DOI : 10.1161/CIRCULATIONAHA.105.559633

D. Lawlor, D. Smith, G. Ebrahim, and S. , Does the new International Diabetes Federation definition predict CHD any more strongly than other definitions ? Findings from the British Women's Heart and Health Study, Diabetologia, vol.23, pp.1-8, 2005.

K. Frayn, Visceral fat and insulin resistance ??? causative or correlative?, British Journal of Nutrition, vol.4, issue.S1, pp.71-77, 2000.
DOI : 10.1002/ajp.1350350102

URL : https://www.cambridge.org/core/services/aop-cambridge-core/content/view/762C6034F2BEAF4605A5C699CA78B052/S0007114500000982a.pdf/div-class-title-visceral-fat-and-insulin-resistance-causative-or-correlative-div.pdf

J. Oppert, M. Charles, N. Thibult, B. Guy-grand, E. Eschwege et al., Anthropometric estimates of muscle and fat mass in relation to cardiac and cancer mortality in men: the Paris Prospective Study The influence of body fat distribution on the incidence of diabetes mellitus. 13,5 years of follow-up of the participants in the study of men born in 1913, Am J Clin Nutr. Diabetes, vol.75, issue.34, pp.1055-1058, 1985.

A. Garg and A. Misra, Lipodystrophies: rare disorders causing metabolic syndrome, Endocrinology and Metabolism Clinics of North America, vol.33, issue.2
DOI : 10.1016/j.ecl.2004.03.003

R. Hegele, Phenomics, Lipodystrophy, and the Metabolic Syndrome, Trends in Cardiovascular Medicine, vol.14, issue.4, pp.371-377, 2003.
DOI : 10.1016/j.tcm.2004.02.001

O. Ziegler, A. Trebea, D. Tourpe, P. Bohme, D. Quilliot et al., Tissu adipeux visc??ral : r??le majeur dans le syndrome m??tabolique, Cahiers de Nutrition et de Di??t??tique, vol.42, issue.2, p.5, 2007.
DOI : 10.1016/S0007-9960(07)88706-2